Læknablaðið - 15.05.1998, Síða 36

396
LÆKNABLAÐIÐ 1998; 84
Fræðigreinar íslenskra iækna í erlendum tímaritum
Getið er fræðigreina og -ágripa. Sendið
heiti greinar, nöfn höfunda og birtingarstað
til Læknablaðsins. Miðað er við greinar sem
birst hafa á yfirstandandi og síðasta ári. Til
glöggvunar verður íslenskra höfunda getið
með fornafni þótt þess sé ekki getið við
birtingu.
* Kristján Guðmundsson, Þórður Harðar-
son, Helgi Sigvaldason, Nikulás Sigfússon.
Sambandet mellan utbildning och riskfaktor
för kranskarlssjukdomar. Nord Med 1997; 5:
169-75.
* Sigurjón Vilbergsson, Gunnar Sigurðs-
son Helgi Sigvaldason, Ástráður B. Hreið-
arsson, Nikulás Sigfússon. Prevalence and
Incidence of NIDDM in lceland: Evidence for
Stable Incidence Among Males and Females
1967-1991 - The Reykjavik Study. Diabetic
Med 1997; 14: 491-8.'
* Ársæll Jónsson, Helgi Sigvaldason,
Nikulás Sigfússon. Total cholesterol and mor-
tality after age of 80 years. Lancet 1997; 350:
1778. '
* Vilmundur Guðnason, Gunnar Sigurðs-
son, Nissen H, Humphries S. Common
Founder Mutation in the LDL Receptor Gene
Causing Familial Hypercholesterolemia in the
Icelandic Population. Hum Mutation 1997; 10:
36-44.
* Peacock RE, Temple A, Vilmundur
Guðnason, Rosseneu M, Humphries SE.
Variation at the Lipoprotein Lipase and
Apolipoprotein A1 - CUI Gene Loci Are Associ-
ated With Fasting Lipid and Lipoprotein Traits
in a Population Sample from Iceland: Interac-
tion between Genotype, Gender, and Smoking
Status. Gen Epidemiol 1997; 14: 265- 82.
* Vilmundur Guðnason, Þormar K,
Humphries SE. Interaction of the cholesteryl
ester transfer protein I405V polymorphism
with alcohol consumption in smoking and non-
smoking healthy men, and the ejfect on plasma
HDL cholesterol and apoAI concentration.
Clin Genetics 1997; 51: 15-21.
* Day INM, Whittall R, O’Dell S, Haddad
L, Bolla M, Vilmundur Guðnason, Hump-
hries S. Spectrum ofLDL receptor gene muta-
tions in lieterozygous familial hyper- cholester-
olaemia. Hum Mutation 1997; 10: 116-27.
* Humphries S, Vilmundur Guðnason,
Whittall R, Day INM. Single strand con-
formation polymorphism analysis with high
throughput modification, and its use in muta-
tion detection infamilial hypercholesterolaem-
ia. For the International Federation of Clinical
Chemistry Scientific Division: Committee on
Molecular Biology Techniques. Clin Chem
1997;43:427-35.
* Hrafn Tulinius, Nikulás Sigfússon, Helgi
Sigvaldason, Kristín Bjarnadóttir, Laufey
Tryggvadóttir. Risk Factors for Malignant
Diseases: A Cohort Study on a Population of
22, 946 Icelanders. Cancer Epidemiol, Bio-
markers & Prevention 1997; 6: 863-73.
* Salomaa VV, Lundberg V, Uggi Agnars-
son, Radisauskas R, Kirchhoff M, Wilhelm-
sen L, for the MONICA investigators in Nor-
dic countries and Lithuania: Fatalities from
myocardial infarction in Nordic countries and
Lithuania. Eur Heart J 1997; 18: 91-8.
* Vilmundur Guðnason, Stansbie D, Scott
J, Bowron A, Nicaud V, Humphries S, on
behalf of the EARS Group. The C677T
(Thermolabile Alanine/Valine) Polymorphism
in Methylenetetrahydrofolate Reductase (MT-
HFR); its Frequency and Impact on Plasma
Homocysteine Concentration in Different
European Populations. Atherosclerosis 1998;
136: 347-54.
* Vilmundur Guðnason, Zhou T, Thormar
K, Baehring S, Cooper J, Miller G, Hum-
phries SE, Schuster H. Detection of the Low
Density Lipoprotein Receptor Gene PVUII In-
tron 15 Polymorphism Using the Polymerase
Chain Reaction: Association with Plasma
Lipid Traits in Healthy Men and Women. Dis-
ease Markers 1998; 13: 209-20.